Unlike adult mammals, which can repair but not regenerate new nephrons, fish generate nephrons de novo throughout life and after kidney injury. To explore mechanisms of kidney regeneration that could one day be applied to treat renal disease in humans, Diep et al. used the zebrafish as a model to identify and characterise progenitor cells responsible for nephron regeneration. Using transplantation experiments, they traced the source of new adult nephrons back to small aggregates of cells containing kidney progenitors. As previously found for mouse nephrons, individual zebrafish nephrons are derived from multiple nephron progenitors, which the authors suggest have self-renewing properties. Furthermore, gene-expression analyses indicated conservation between mammals and zebrafish with respect to the factors involved in renal development. These results provide hope that nephron progenitors with self-renewing potential might also be present in the human adult kidney and could be coaxed out of a dormant state to stimulate kidney regeneration following injury or disease.
OpenUrlCrossRefPubMedWeb of Science
- Written by editorial staff. © 2011. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Editor's Choice – Lifespan analysis of phenotypes in three mouse models of Down syndrome
A comparison of three mouse models of Down syndrome by Diana W. Bianchi and co-workers reveals widespread and unexpected fundamental differences in behavioural, gene expression and brain development phenotypes.
Find out more about the story behind this Editor's Choice article in an interview with first author Nadine M. Aziz.
Review – Hidden features: exploring the non-canonical functions of metabolic enzymes
A new Review from Peiwei Huangyang and M. Celeste Simon, part of our upcoming special issue on Cancer metabolism, summarizes recent findings about multifaceted metabolic enzymes with non-canonical activities outside their core biochemical functions, and how they may provide new therapeutic strategies for cancers.
Featured article – Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
Gustav Steinhoff and colleagues report that cardiac mesenchymal stem cells respond early to myocardial infarction, and that their regenerative capacity is directly upregulated by optimized stimulation of the heart through epicardial erythropoietin delivery.
First Person interviews
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with first authors Nadine Aziz, Tingting Sui, Brian Lu, Hannah Gordon, Theresa Kisko, Francisco Javier García-Rodríguez and Laura Schultz.
Why should you publish your next paper in DMM?
DMM aims to promote human health by encouraging collaboration between basic and clinical researchers, covering a diverse range of diseases, approaches and models. Our Editors are all active researchers in the field – your peers, colleagues and mentors, who know how much work has gone into every paper. Recently, we have introduced format-free submission, and we accept peer review reports from other journals, making submission as easy as possible for our authors. Send us your next great paper – publish with us and you'll be in good company.
preLights – Using zebrafish to model the effects of candidate disease gene variants in complex human genetic disorders
Highlighted by Hannah Brunsdon, a recent preprint from Lisa Maves and co-workers describes the first example of modelling a complex genetic disorder in zebrafish, and demonstrates that a human candidate disease variant of unknown significance acts as a modifier gene for congenital heart defects.